Mr. Bjerkholt serves as Chief Financial Officer of Mirum Pharmaceuticals, Inc. Mr. Bjerkholt's extensive experience actively overseeing the audit of public company financial statements and the work of independent registered public accounting firms make him a valuable asset to our Audit Committee. Mr. Bjerkholt is consistently prepared and has exemplary participation at meetings of our Board and Audit Committee, as demonstrated by his insightful questions and comments, and he contributes significantly to discussions and decision making. Mr. Bjerkholt's experience in executive management positions in the biotechnology industry provides significant industry knowledge and operational and management expertise to our Board. Mr. Bjerkholt's experience on the boards of directors of other public companies benefits us by providing him with insight and experience that enhances his value to our Board. Mr. Bjerkholt has assured our Board that his ongoing commitments at his outside boards are not expected to exceed demands on his time and attention that existed in past years and will continue to not detract from his service on our Board going forward.